Compare Funko Inc (FNKO) vs Tenet Healthcare Corporation (THC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Funko Inc vs Tenet Healthcare Corporation — how do they compare? Funko Inc trades at $6.49 (market cap $353.05M), while Tenet Healthcare Corporation trades at $260 (market cap $20.92B). The key difference: Tenet Healthcare Corporation is far larger — about 59.3× Funko Inc's market cap, and Funko Inc is more actively traded (915,655 versus 455,764). Which is the better fit depends on your goals — on Pluang, investors hold Funko Inc for 33 Days and Tenet Healthcare Corporation for 15 Days on average.
| FNKO | THC | |
|---|---|---|
Market Cap | $353.05M | $20.92B |
Volume | 915,655 | 455,764 |
Sector | Consumer Cyclical | Health |
52-Week High | $7.10 | $280.77 |
52-Week Low | $2.81 | $161.37 |
Typical Hold Time | 33 Days | 15 Days |
Enterprise Value | $573.70M | $32.00B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
FNKO trades at $6.50, up 6.38% with strong technical momentum and bullish moving averages. The company shows improving fundamentals with Q2 2026 earnings beating expectations, revenue growth of 7% to $207.7M, and raised EBITDA guidance to $105M. Despite negative net margins, the stock trades at attractive valuations with P/S of 0.37 and EV/EBITDA of 6.7x. Recent management changes and product expansions signal strategic repositioning.
FNKO presents a turnaround opportunity with improving operational metrics and analyst consensus target of $7.58 (17% upside). Key risks include persistent negative profitability, high debt levels, and consumer discretionary sensitivity. The bullish technical setup combined with fundamental improvements supports cautious optimism for value investors seeking exposure to pop culture branding.
Tenet Healthcare (THC) trades at $259.83, up 0.53% with strong technical momentum and bullish moving average signals. The company demonstrates robust fundamentals with consistent earnings beats (Q4 2025-Q2 2026), 82.83% gross margins, and 53.31% ROE. Recent news highlights strong cash flow supporting capital returns, with Q3 2026 results expected October 29, 2026.
THC presents compelling value with a 10.04 P/E ratio and 81.25% analyst buy ratings. Upside potential to $283.36 consensus target exists, though negative cash flow trends and insider selling warrant monitoring. The stock's premium valuation (P/B 4.49) requires sustained execution amid healthcare sector volatility.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Funko Inc
Funko Inc is a US-based pop culture consumer products company. It creates whimsical, fun, and different products which enable the customer to express their affinity for their favorite through movie, TV show, video game, musician or sports team. The company holds licenses and the rights to create tens of thousands of characters including Game of Thrones, Walking Dead, Disney, Marvel, Harry Potter, Fallout, and others. Its products include Pop, Dorbz, Mystery Vinyl, Plush, Action Figures, and Others. The company sells its products through a diverse network of retail customers across multiple retail channels, including specialty retailers, mass-market retailers, and e-commerce sites.
Read more on FNKO →About Tenet Healthcare Corporation
Tenet Healthcare is a leading diversified healthcare services company that has strategically pivoted toward high-growth ambulatory care. Operating through United Surgical Partners International (USPI), the largest ambulatory platform in the U.S., Tenet manages an expansive network of surgical centers, acute care hospitals, and specialty facilities. The company’s focus on high-acuity services and operational efficiency, supported by its revenue cycle management subsidiary Conifer Health Solutions, positions it as a resilient leader in the evolving U.S. healthcare landscape.
Read more on THC →
